Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haixuan Wen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Aging|January 24, 2024
Potential prognosis and immunotherapy predictor TFAP2A in pan-cancerChenxi Niu, Haixuan Wen, Shutong Wang, et al.
Journal of Cancer|July 14, 2025
Alternative splicing factor RAB3IP as a novel risk signature to predict the prognosis of colorectal cancerZhengwei Zhou, Fei Gao, Han Lei, et al.
Materials Today. Bio|November 10, 2025
Bioinformatics driven in gene targeting platform for gold anticancer strategy deliveryCan Jiang, Haixuan Wen, Jiabin Chen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Aging|January 24, 2024
Potential prognosis and immunotherapy predictor TFAP2A in pan-cancerChenxi Niu, Haixuan Wen, Shutong Wang, et al.
Journal of Cancer|July 14, 2025
Alternative splicing factor RAB3IP as a novel risk signature to predict the prognosis of colorectal cancerZhengwei Zhou, Fei Gao, Han Lei, et al.
Materials Today. Bio|November 10, 2025
Bioinformatics driven in gene targeting platform for gold anticancer strategy deliveryCan Jiang, Haixuan Wen, Jiabin Chen, et al.
Pageof 1